English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Conference Paper

Comprehensive quantitative proteomic profiling of lung cancers reveals novel biomarkers and potential drug targets.

MPS-Authors
/persons/resource/persons85543

Lenz,  C.
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons98150

Corso,  J.
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15947

Urlaub,  H.
Research Group of Bioanalytical Mass Spectrometry, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Bohnenberger, H., Ströbel, P., Henric-Petri, H., Lenz, C., Emmert, A., Bremmer, F., et al. (2014). Comprehensive quantitative proteomic profiling of lung cancers reveals novel biomarkers and potential drug targets. Cancer Research, 74(Supplement S): 2487.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0028-161E-C
Abstract
There is no abstract available